Uridine 5'-diphosphate sodium salt is a selective native agonist of the P2Y6 receptor (EC50: 300 nM; pEC50: 6.52), and also is a potent antagonist of P2Y14 (pEC50: 7.28).

microglial CCL2 and CCL3 mRNA expression significantly induced by Uridine 5'-diphosphate sodium salt (100 μM; for 15 min)[2]. Uridine 5'-diphosphate sodium salt (100 μM; 3 hours) induces chemokine expression in microglia[2]. Uridine 5'-diphosphate sodium salt (100 μM; 0.5, 1, 3, 6 12 hours) induces expression of mRNA encoding CCL2 and CCL3 within 30 min, and such expression reaches maximal levels at 1 h, returning to basal levels at 3-12 h[2]. UDP (10, 100, 1000 μM; 3 hours) induces a concentration-dependent increase in the expression of chemokines at both the mRNA and protein level[2]. Activation of NFATc1 and NFATc2 in microglia induced by Uridine 5'-diphosphate sodium salt (100 μM; for 15 min) [2].

21931-53-3

C9H11N2Na3O12P2

470.106

Uridine 5'-diphosphate sodium salt

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years